InvestSMART

Genera Biosystems Limited (ASX: GBI) - Announcements

DELISTED - Current share price for GBI : $0.160

ASX company news and announcements for Genera Biosystems Limited (GBI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genera Biosystems Limited (GBI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genera Biosystems Limited (GBI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genera Biosystems Limited (GBI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Trading Halt 20 Jan 2010 9:22AM $0.770 $0.160 fallen by 79.22%
- TGA Application for PapType 19 Nov 2009 10:06AM $0.890 $0.160 fallen by 82.02%
- Placement 5 Nov 2009 9:15AM $0.830 $0.160 fallen by 80.72%
- Appendix 4C - quarterly 22 Oct 2009 5:48PM $0.885 $0.160 fallen by 81.92%
- Quality System Certification and Licence to Manufacture 15 Oct 2009 9:20AM $0.800 $0.160 fallen by 80%
- Results of Major Clinical Study-Genera Biosystems` PapType 4 Sep 2009 9:44AM $0.685 $0.160 fallen by 76.64%
- Appendix 4E Preliminary Final Report 26 Aug 2009 3:02PM $0.700 $0.160 fallen by 77.14%
- Appendix 4C - quarterly 27 Jul 2009 3:37PM $0.470 $0.160 fallen by 65.96%
- Capital Raising Notice prior to end of Trading Halt period 18 May 2009 6:50PM $0.470 $0.160 fallen by 65.96%
- Trading Halt 15 May 2009 9:26AM $0.470 $0.160 fallen by 65.96%
- Appendix 4C - quarterly and Company Update 30 Apr 2009 1:33PM n/a $0.160 n/a
- PapType cervical cancer test- data release. 8 Apr 2009 10:48AM $0.415 $0.160 fallen by 61.45%
- Appendix 4D Half Yearly Report and Accounts 24 Feb 2009 4:43PM $0.210 $0.160 fallen by 23.81%
- Appendix 4C - quarterly 22 Jan 2009 6:44PM $0.220 $0.160 fallen by 27.27%
- Clarification of Media Report in the AFR 21st January 09 21 Jan 2009 10:05AM $0.220 $0.160 fallen by 27.27%
- Australian Patent Granted 9 Jan 2009 1:06PM $0.230 $0.160 fallen by 30.43%
- Appendix 4C - quarterly 31 Oct 2008 2:35PM $0.180 $0.160 fallen by 11.11%
- PapType passes pilot study in clinical trials 15 Oct 2008 10:58AM $0.170 $0.160 fallen by 5.88%
- Genera Biosystems-Issue of Entitlement Options 9 Sep 2008 10:58AM $0.190 $0.160 fallen by 15.79%
- Preliminary Final Report 25 Aug 2008 7:30PM n/a $0.160 n/a
- Appendix 4C - quarterly 31 Jul 2008 9:03AM n/a $0.160 n/a
- Company Presentation 10 Jul 2008 10:40AM n/a $0.160 n/a
- Commercial Sales Agreement with Healthscope 20 Jun 2008 9:56AM $0.410 $0.160 fallen by 60.98%
- Pre - quotation disclosure 10 Jun 2008 12:11PM $0.450 $0.160 fallen by 64.44%
- Admission to Official List 10 Jun 2008 11:53AM n/a $0.160 n/a

251 - 275 of 275 results

Page 11 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.